Inappropriately repeated lipid tests in a tertiary hospital in Greece: the magnitude and cost of the phenomenon.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3738735)

Published in Hippokratia on July 01, 2012

Authors

V Iliadi1, C Kastanioti, G Maropoulos, D Niakas

Author Affiliations

1: Department of Medical Biopathology, General Hospital of Athens Laiko, Athens, Greece.

Articles citing this

Unnecessary repeated total cholesterol tests in biochemistry laboratory. Biochem Med (Zagreb) (2016) 0.75

Articles cited by this

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Standards of medical care in diabetes--2008. Diabetes Care (2008) 17.23

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50

The distinction between cost and charges. Ann Intern Med (1982) 5.93

Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA (1998) 3.96

Does the computerized display of charges affect inpatient ancillary test utilization? Arch Intern Med (1997) 2.01

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90

Population-based study of repeat laboratory testing. Clin Chem (2003) 1.85

Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: a cluster randomised trial. Lancet (2006) 1.78

Selective ordering of preoperative investigations by anesthesiologists reduces the number and cost of tests. Can J Anaesth (2005) 1.65

Rationale for cost-effective laboratory medicine. Clin Microbiol Rev (1994) 1.60

Factors contributing to inappropriate ordering of tests in an academic medical department and the effect of an educational feedback strategy. Postgrad Med J (2006) 1.57

Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol (2007) 1.53

Managing abnormal blood lipids: a collaborative approach. Circulation (2005) 1.44

An administrative intervention to improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care (2005) 1.36

The effect of price information on test-ordering behavior and patient outcomes in a pediatric emergency department. Pediatrics (1999) 1.22

Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem (2003) 1.12

The short-term effect on technical and scale efficiency of establishing regional health systems and general management in Greek NHS hospitals. Health Policy (2007) 1.04

Test-ordering by multiple physicians increases unnecessary laboratory examinations. Arch Pathol Lab Med (1988) 1.02

A cost-effective method for reducing the volume of laboratory tests in a university-associated teaching hospital. Mt Sinai J Med (2006) 1.01

The responsible use of the clinical laboratory. Clin Biochem (1986) 0.94

Laboratory testing in the intensive care unit. Crit Care Clin (2007) 0.94

Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol (2001) 0.93

Cost-consciousness among Swiss doctors: a cross-sectional survey. BMC Health Serv Res (2005) 0.93

Is there duplication of diagnostic test results? Can Med Assoc J (1975) 0.88

Appropriate utilization and cost control of the hospital laboratory: panel testing and repeat orders. Clin Chim Acta (1995) 0.87

Cost analysis of laboratory tests: a study of the Central Laboratory of King Chulalongkorn Memorial Hospital. J Med Assoc Thai (2004) 0.87

The profit potential of hospital labs. Hosp Health Netw (2008) 0.87

A successful experiment to reduce unnecessary laboratory use in a community hospital. Med Care (1988) 0.86

A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients. BMC Nephrol (2002) 0.80

Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function. Int Urol Nephrol (2008) 0.79